Xiaobin Wu, President, COO & GM China at BeiGene, Ltd. (BGNE), sold 103,842 shares at $240.07 ($25.0M) on 2025-02-20, disclosed to the SEC on 2025-02-20.
Scheduled sale ($25.0M) by President, COO & GM China under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.31 | 19,576 | $4.7M | 18.8% |
| 2 | $240.31 | 19,576 | $4.7M | 18.8% |
| 3 | $241.26 | 7,919 | $1.9M | 7.7% |
| 4 | $241.26 | 7,919 | $1.9M | 7.7% |
| 5 | $242.08 | 3,159 | $765K | 3.1% |
| 6 | $242.08 | 3,159 |
| $765K |
| 3.1% |
| 7 | $240.07 | 21,267 | $5.1M | 20.4% |
| 8 | $240.07 | 21,267 | $5.1M | 20.4% |
| Total | $240.46 avg | 103,842 | $25.0M | 100% |
| Filing → |
| ONC | SELL | 2026-06-18 | $362K | — | Filing → |
| ONC | SELL | 2026-06-15 | $164K | — | Filing → |
| ONC | SELL | 2026-06-10 | $400K | — | Filing → |